Literature DB >> 7676971

Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis?

D A Lynch1, J D Newell, P M Logan, T E King, N L Müller.   

Abstract

OBJECTIVE: The clinical management of patients with idiopathic pulmonary fibrosis differs markedly from that of patients with hypersensitivity pneumonitis. However, the two diseases often cannot be differentiated on clinical grounds. The purpose of this study was to establish whether CT can be used to make the distinction.
MATERIALS AND METHODS: Thirty-six patients with idiopathic pulmonary fibrosis and 27 patients with hypersensitivity pneumonitis were studied. All diagnoses were confirmed or supported by open lung biopsy. Three of the patients with idiopathic pulmonary fibrosis had desquamative interstitial pneumonia, and the remainder had usual interstitial pneumonia. In 19 of the 27 patients with hypersensitivity pneumonitis, the disease was chronic (symptoms lasting more than 1 year), while eight had acute or subacute symptoms. Two radiologists, who had not previously seen any of the cases and were blinded to the diagnosis, reviewed the CT images by consensus. The extent and distribution of CT features (including ground-glass attenuation, honeycombing, and micronodules) were recorded. In each case, a CT diagnosis was made, and the level of diagnostic confidence was recorded.
RESULTS: A CT diagnosis was made with a high level of confidence in 39 (62%) of 63 patients. In these patients, the CT diagnosis was correct in 35 cases (90%): 23 of 26 patients with a CT diagnosis of idiopathic pulmonary fibrosis and 12 of 13 patients with a CT diagnosis of hypersensitivity pneumonitis. In the three patients with desquamative interstitial pneumonia, the CT diagnoses were probable hypersensitivity pneumonitis in two cases and definite hypersensitivity pneumonitis in one case. Of the 19 patients with chronic hypersensitivity pneumonitis, only seven had a definite diagnosis of hypersensitivity pneumonitis based on CT findings; three had a definite diagnosis of idiopathic pulmonary fibrosis. The patients with idiopathic pulmonary fibrosis and usual interstitial pneumonia were more likely to have honeycombing and peripheral or lower lung zone predominance of disease, and less likely to have micronodules, than were patients with chronic hypersensitivity pneumonitis. The patients with idiopathic pulmonary fibrosis and desquamative interstitial pneumonia had widespread ground-glass opacity indistinguishable from some cases of acute or subacute hypersensitivity pneumonitis.
CONCLUSION: Our results show that CT can be used to distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis in most but not all cases. Desquamative interstitial pneumonia cannot reliably be distinguished from acute or subacute hypersensitivity pneumonitis. Chronic hypersensitivity pneumonitis may have findings identical to those of usual interstitial pneumonia. Lung biopsy should still be considered the gold standard for diagnosis of interstitial lung disease.

Entities:  

Mesh:

Year:  1995        PMID: 7676971     DOI: 10.2214/ajr.165.4.7676971

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  30 in total

Review 1.  Clinical usefulness of high resolution computed tomography in cryptogenic fibrosing alveolitis.

Authors:  A Wells
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

2.  73-year-old woman with progressive shortness of breath.

Authors:  John E Moss; Michael J Maniaci; Margaret M Johnson
Journal:  Mayo Clin Proc       Date:  2010-01       Impact factor: 7.616

3.  A comparison of health-related quality of life in idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.

Authors:  Molly Lubin; Hubert Chen; Brett Elicker; Kirk D Jones; Harold R Collard; Joyce S Lee
Journal:  Chest       Date:  2014-06       Impact factor: 9.410

4.  A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective.

Authors:  Christopher J Ryerson; Tamera J Corte; Joyce S Lee; Luca Richeldi; Simon L F Walsh; Jeffrey L Myers; Jürgen Behr; Vincent Cottin; Sonye K Danoff; Kevin R Flaherty; David J Lederer; David A Lynch; Fernando J Martinez; Ganesh Raghu; William D Travis; Zarir Udwadia; Athol U Wells; Harold R Collard
Journal:  Am J Respir Crit Care Med       Date:  2017-11-15       Impact factor: 21.405

Review 5.  Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to Go.

Authors:  Margaret L Salisbury; Jeffrey L Myers; Elizabeth A Belloli; Ella A Kazerooni; Fernando J Martinez; Kevin R Flaherty
Journal:  Am J Respir Crit Care Med       Date:  2017-09-15       Impact factor: 21.405

6.  A diagnostic model for chronic hypersensitivity pneumonitis.

Authors:  Kerri A Johannson; Brett M Elicker; Eric Vittinghoff; Deborah Assayag; Kaïssa de Boer; Jeffrey A Golden; Kirk D Jones; Talmadge E King; Laura L Koth; Joyce S Lee; Brett Ley; Paul J Wolters; Harold R Collard
Journal:  Thorax       Date:  2016-05-31       Impact factor: 9.139

7.  Development and validation of a radiological diagnosis model for hypersensitivity pneumonitis.

Authors:  Margaret L Salisbury; Barry H Gross; Aamer Chughtai; Mohamed Sayyouh; Ella A Kazerooni; Brian J Bartholmai; Meng Xia; Susan Murray; Jeffrey L Myers; Amir Lagstein; Kristine E Konopka; Elizabeth A Belloli; Jamie S Sheth; Eric S White; Colin Holtze; Fernando J Martinez; Kevin R Flaherty
Journal:  Eur Respir J       Date:  2018-08-16       Impact factor: 16.671

Review 8.  Idiopathic interstitial pneumonias: progress in classification, diagnosis, pathogenesis and management.

Authors:  Talmadge E King
Journal:  Trans Am Clin Climatol Assoc       Date:  2004

Review 9.  Pulmonary Aspergillosis: What CT can Offer Before it is too Late!

Authors:  Akhila Prasad; Kshitij Agarwal; Desh Deepak; Swapndeep Singh Atwal
Journal:  J Clin Diagn Res       Date:  2016-04-01

10.  Clues for the differential diagnosis of hypersensitivity pneumonitis as an expectant variant of diffuse parenchymal lung disease.

Authors:  E Küpeli; D Karnak; O Kayacan; S Beder
Journal:  Postgrad Med J       Date:  2004-06       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.